Germany boosts own vaccine makers in race for COVID-19 jab

Germany says it is providing up to $892 million to support three domestic pharmaceutical companies that are developing vaccines against the new coronavirus

Talks with a third company, IDT Biologika, are expected to conclude soon, she said. The company is developing a vector-based vaccine that delivers a coronavirus protein into cells to stimulate the body's immune response.